IL31RA and ovarian cancer: Switching to ovarian cancer, the JNK-STAT pathway in tumor invasion and metastasis is activated by IL-31 in the overexpressing, tumoral cells (IL-31RA+), with a possible correlation with different clinical presentation and prognosis [93].